Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Bangor, Maine 04401


Purpose:

The purpose of this phase 3 study is to determine the safety and efficacy of cyclosporine in the treatment of dry eye syndrome.


Criteria:

Inclusion Criteria: - Diagnosis of moderate to severe dry eye syndrome with or without Sjogren's syndrome or other autoimmune disease Exclusion Criteria: - Intraocular or refractive surgery in the study eye within 3 months prior to study start - Unwilling to discontinue use of contact lenses during the run-in and duration of the study - Pregnancy or lactation


NCT ID:

NCT00548301


Primary Contact:

Study Chair
Roger Vogel, MD
Sirion Therapeutics


Backup Contact:

N/A


Location Contact:

Bangor, Maine 04401
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: November 19, 2017

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.